Global Bioidentical Hormones Market Size Forecast 2024 - 2033
13 Dec, 2024
What Is The Definition Of The Global Bioidentical Hormones Market?
Bioidentical hormones are compounds that are chemically identical to the hormones naturally produced by the human body and are used primarily in hormone replacement therapy to treat hormone imbalances. These are employed to alleviate symptoms associated with menopause, andropause, and other hormonal deficiencies, such as hot flashes, night sweats, mood swings, and low libido.
Bioidentical Hormones Global Market Report 2024 provides data on the global bioidentical hormones market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The bioidentical hormones market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.
How Is The Global Bioidentical Hormones Market Size Expected To Change, And What Are The Growth Rate Projections?
The bioidentical hormones market has shown robust growth in recent years. It is expected to grow from $7.05 billion in 2023 to $7.49 billion in 2024, at a CAGR of 6.3%. Factors driving growth in the past include rising awareness of hormone-related health issues, increased prevalence of hormonal imbalances, an aging population, higher healthcare expenditures, and a greater demand for alternative medicine. By 2028, the market is expected to grow to $9.60 billion at a CAGR of 6.4%. Contributing factors include a focus on women’s health, growing acceptance of personalized medicine, supportive government policies, the rising prevalence of chronic diseases, and greater awareness of the benefits of bioidentical hormones. Key trends expected to shape the market include the development of novel hormone formulations, increased use of telemedicine for consultations, greater integration into mainstream medicine, advancements in hormone delivery systems, and the expanding role of biotechnology in hormone production.
Which Drivers Are Accelerating Growth In The Bioidentical Hormones Market?
The increasing demand for personalized medicine is anticipated to drive the bioidentical hormones market. Personalized medicine tailors treatments to individuals based on factors such as genetics and lifestyle, optimizing effectiveness and minimizing side effects. The demand for personalized medicine is rising due to its potential to provide more effective treatments, advancements in genomics, and the increasing complexity of diseases. Bioidentical hormones align with personalized medicine by offering treatments that match an individual’s hormonal profile, improving treatment outcomes and minimizing side effects. The Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized therapies for rare diseases, up from six in 2022. Thus, the increasing demand for personalized medicine is propelling the bioidentical hormones market.
Get Your Free Sample of the Global Bioidentical Hormones Market ReportWhat Are The Core Segments Of The Global Bioidentical Hormones Market?
The bioidentical hormones market covered in this report is segmented –
1) By Type: Estrogen, Progesterone, Testosterone, Other Types
2) By Product Type: Tablet And Capsule, Cream And Gel, Patch And Implant, Injectable, Other Product Types
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Menopause Management, Hormone Replacement Therapy (HRT), Thyroid Disorders, Andropause Management
5) By End-use: Hospitals, Gynecology Clinics, Research Laboratories, Other End-Users
Which Emerging Trends Are Reshaping The Bioidentical Hormones Market Size?
In the bioidentical hormones market, companies are developing advanced solutions like bioidentical hormone replacement therapy (BHRT) to offer more effective and personalized treatments for hormonal imbalances. BHRT uses hormones that are chemically identical to those naturally produced by the human body to treat hormone-related conditions. For example, in May 2024, Jagsonpal Pharmaceuticals Limited, an India-based pharmaceutical company, introduced MemUp HRT, a US FDA-approved bioidentical hormone therapy. This product combines bioidentical estradiol and progesterone in a single pill formulation to improve patient compliance, raising awareness about menopause management and expanding healthcare options for women in India.
What Is The Largest Region In The Bioidentical Hormones Market?
North America was the largest region in the bioidentical hormones market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioidentical hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.